Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma

Immune activation is essential for the antitumor activity of EZH2

Interaction of microRNAs with sphingosine kinases, sphingosine-1

Long non-coding RNAs and exosomal lncRNAs: Potential functions in

R2 Genomics Analysis and Visualization Platform

Mechanisms behind the Resistance to Trastuzumab in HER2-Amplified

Insights into a Crucial Role of TRIP13 in Human Cancer

Homeostatic Proliferation Inhibitors

Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of

Long non-coding RNAs and exosomal lncRNAs: Potential functions in

Aberrant activation of TRIP13-EZH2 signaling axis promotes

Strategic Combinations to Prevent and Overcome Resistance to

TRIP13 Gene - GeneCards, PCH2 Protein